About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Sptlc3em1Cowl
endonuclease-mediated mutation 1, L Ashley Cowart
MGI:7858938
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Sptlc3em1Cowl/Sptlc3em1Cowl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
involves: C57BL/6 * DBA MGI:7858939


Genotype
MGI:7858939
cn1
Allelic
Composition
Sptlc3em1Cowl/Sptlc3em1Cowl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Genetic
Background
involves: C57BL/6 * DBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Speer6-ps1Tg(Alb-cre)21Mgn mutation (6 available); any Speer6-ps1 mutation (4 available)
Sptlc3em1Cowl mutation (0 available); any Sptlc3 mutation (30 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
liver/biliary system
N
• no apparent differences in steatosis, hepatomegaly, liver triglyceride levels, liver glycogen levels, or markers of inflammation when fed a high fat diet compared to diet matched controls
• primary hepatocytes cultured in glucose free medium accumulate only 50 uM glucose in the medium compared to ~125 uM for controls
• expression of genes related to gluconeogenesis is low in primary hepatocytes related to controls and fails to increase in response to glucagon treatment
• labeled-metabolite analysis indicates that the impairment is primarily due to suppressed conversion of oxalacetate to PEP and downstream metabolites
• glucagon induced increase in cAMP levels is impaired and addition of a cell permeable cAMP derivative increases expression of gluconeogenesis related genes

homeostasis/metabolism
• on a high-fat diet mice do not display the expected increase in fasting glucose levels seen in diet matched controls
• primary hepatocytes cultured in glucose free medium accumulate only 50 uM glucose in the medium compared to ~125 uM for controls
• expression of genes related to gluconeogenesis is low in primary hepatocytes related to controls and fails to increase in response to glucagon treatment
• labeled-metabolite analysis indicates that the impairment is primarily due to suppressed conversion of oxalacetate to PEP and downstream metabolites
• in mice on a high-fat diet compared to diet matched controls
• glucose tolerance test indicate a partial protection from high-fat diet induced diabetes
• however, high-fat diet induced increase in postprandial insulin levels is similar to diet matched controls





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/17/2024
MGI 6.24
The Jackson Laboratory